Marketable Securities

3 Months Ended

Sep. 30, 2018

Investments, Debt and Equity Securities [Abstract]

Marketable Securities

Marketable Securities

Immunomedics considers all of its current investments to be available-for-sale. Marketable securities at September 30, 2018 consisted of the following (in thousands):

	Amortized Cost		Gross Unrealized Gain		Gross Unrealized (Loss)		Fair Value
U.S. Government Sponsored Agencies	$	4,941	$	—	$	—	$	4,941

Maturities of debt securities classified as available-for-sale were as follows at September 30, 2018 (in thousands):

	Fair Value		Net Carrying Amount
Due after one year through five years	$	4,941	$	4,954

Marketable securities at June 30, 2018 consisted of the following (in thousands):

	Amortized Cost		Gross Unrealized Gain		Gross Unrealized (Loss)			Fair Value
U.S. Treasury Bonds	$	9,641	$	—	$	(9	)	$	9,632
Certificate of Deposits	5,610		—		—			5,610
U.S. Government Sponsored Agencies	6,751		—		(2		)	6,749
Corporate Debt Securities	4,510		—		(5		)	4,505
Commercial Paper	249		—		—			249
	$	26,761	$	—	$	(16	)	$	26,745

Maturities of debt securities classified as available-for-sale were as follows at June 30, 2018 (in thousands):

	Fair Value		Net Carrying Amount
Due within one year	$	21,745	$	21,860
Due after one year through five years	5,000		5,009
	$	26,745	$	26,869